HeadInvest LLC’s DexCom DXCM Stock Holding History

HeadInvest LLC’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-100	Closed	-$9.46K	–	347
2023 Q3	$9.46K	Buy	+100	New	+$11.3K	﹤0.01%	562

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

HeadInvest LLC's DXCM Position: Q4 2023 in Review

HeadInvest LLC sold out of DexCom (DXCM) in Q4 2023, closing a stake of 100 shares — an estimated $9.46K sold.

HeadInvest LLC first reported a position in DXCM in Q3 2023 and held it in 1 quarter. The position peaked at $9.46K in Q3 2023. 974 funds tracked by Wall St. Rank hold DXCM as of Q4 2023.

HeadInvest LLC reported no remaining DexCom position as of Q4 2023 after selling out during the quarter.
HeadInvest LLC sold 100 DexCom shares in Q4 2023, an estimated $9.46K.
HeadInvest LLC first reported a position in DexCom in Q3 2023 and held it in 1 quarter.
HeadInvest LLC's DexCom position peaked at $9.46K in Q3 2023.
974 funds tracked by Wall St. Rank held DexCom as of Q4 2023.

Based on HeadInvest LLC's 13F filing for Q4 2023, filed 12 Feb 2024.